Clinical Trial Update: Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares monotherapy with mirabegron or tolterodine to combined mirabegron-tolterodine therapy on autonomic function and bladder bloo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Mirabegron (mirabegron)
• Tolterodine (tolterodine)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Female Patients With Overactive Bladder Syndrome | Phase 4 | Status: UNKNOWN